Synopsys offers remedies to address EU concerns over Ansys deal
Published by Global Banking and Finance Review
Posted on December 10, 2024
1 min readLast updated: January 27, 2026

Published by Global Banking and Finance Review
Posted on December 10, 2024
1 min readLast updated: January 27, 2026

Synopsys offers remedies to address EU concerns over its $35 billion acquisition of Ansys, the largest tech deal since Broadcom's VMware purchase.
BRUSSELS (Reuters) - Chip design software company Synopsys has offered remedies to address EU antitrust concerns about its $35 billion cash-and-stock acquisition of engineering software maker Ansys, according to a European Commission filing on Tuesday.
The deal, announced in January, is the biggest in the technology sector since chipmaker Broadcom's $69 billion buy of software maker VMware last November.
(Reporting by Foo Yun Chee, Editing by Louise Heavens)
The main topic is Synopsys offering remedies to address EU antitrust concerns over its acquisition of Ansys.
The Synopsys-Ansys deal is valued at $35 billion in cash and stock.
The European Commission is reviewing the deal due to antitrust concerns that Synopsys is addressing with proposed remedies.
Explore more articles in the Finance category



